Cargando…

DNA Mismatch Repair Protein Immunohistochemistry and MLH1 Promotor Methylation Testing for Practical Molecular Classification and the Prediction of Prognosis in Endometrial Cancer

The incidence of endometrial cancer is rapidly increasing worldwide, and its molecular classification has gained importance for new therapeutic approaches. This study sought to examine the clinicopathologic features and immune markers associated with the DNA mismatch repair (MMR) status and MLH1 pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jisup, Kong, Jin Kyoung, Yang, Wookyeom, Cho, Hanbyoul, Chay, Doo Byung, Lee, Bang Hyun, Cho, Seong Jin, Hong, Soonwon, Kim, Jae-Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162750/ https://www.ncbi.nlm.nih.gov/pubmed/30134578 http://dx.doi.org/10.3390/cancers10090279

Ejemplares similares

Nectin-4 as a Predictive Marker for Poor Prognosis of Endometrial Cancer with Mismatch Repair Impairment
por: Chang, Ha Kyun, et al.
Publicado: (2023)

Establishment of five immortalized human ovarian surface epithelial cell lines via SV40 T antigen or HPV E6/E7 expression
por: Shin, Ha-Yeon, et al.
Publicado: (2018)

Isolated MLH1 Loss by Immunohistochemistry Because of Benign Germline MLH1 Polymorphisms
por: Bosch, Dustin E., et al.
Publicado: (2022)

MLH1 promoter hypermethylation predicts poorer prognosis in mismatch repair deficiency endometrial carcinomas
por: Kaneko, Enami, et al.
Publicado: (2021)

Mismatch repair protein and MLH1 methylation status as predictors of response to adjuvant therapy in endometrial cancer
por: Loukovaara, Mikko, et al.
Publicado: (2021)

Prognostic implications of forkhead box protein O1 (FOXO1) and paired box 3 (PAX3) in epithelial ovarian cancer
por: Han, Gwan Hee, et al.
Publicado: (2019)

Comparison of Clinical Features and Outcomes in Epithelial Ovarian Cancer according to Tumorigenicity in Patient-Derived Xenograft Models
por: Eoh, Kyung Jin, et al.
Publicado: (2018)

The Role of Immunohistochemistry Markers in Endometrial Cancer with Mismatch Repair Deficiency: A Systematic Review
por: Favier, Amelia, et al.
Publicado: (2022)

Screening of Lynch syndrome in endometrial cancer in Iranian population with mismatch repair protein by immunohistochemistry
por: Noei Teymoordash, Somayyeh, et al.
Publicado: (2022)

Sessile serrated adenomas with dysplasia: morphological patterns and correlations with MLH1 immunohistochemistry
por: Liu, Cheng, et al.
Publicado: (2017)

Mutational Analysis of Mismatch Repair Genes, hMLH1 and hMSH2, in Sporadic Endometrial Carcinomas with Microsatellite Instability
por: Kobayashi, Kanji, et al.
Publicado: (1996)

Mismatch Repair Genes Mlh1 and Mlh3 Modify CAG Instability in Huntington's Disease Mice: Genome-Wide and Candidate Approaches
por: Pinto, Ricardo Mouro, et al.
Publicado: (2013)

MLH1 enhances the sensitivity of human endometrial carcinoma cells to cisplatin by activating the MLH1/c-Abl apoptosis signaling pathway
por: Li, Yue, et al.
Publicado: (2018)

Mlh2 Is an Accessory Factor for DNA Mismatch Repair in Saccharomyces cerevisiae
por: Campbell, Christopher S., et al.
Publicado: (2014)

Estrogen enhances mismatch repair by induction of MLH1 expression via estrogen receptor-β
por: Lu, Jun-Yu, et al.
Publicado: (2017)

Discordant immunohistochemistry in an unusual MLH1 gene variant in a case of Lynch syndrome
por: Nagabhushana, Prerana, et al.
Publicado: (2021)

The mismatch repair and meiotic recombination endonuclease Mlh1-Mlh3 is activated by polymer formation and can cleave DNA substrates in trans
por: Manhart, Carol M., et al.
Publicado: (2017)

Clinical Significance of CA125 Level after the First Cycle of Chemotherapy on Survival of Patients with Advanced Ovarian Cancer
por: Lee, Maria, et al.
Publicado: (2016)

Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification
por: Karnezis, Anthony N, et al.
Publicado: (2017)

Identification of Prognostic Markers of Gynecologic Cancers Utilizing Patient-Derived Xenograft Mouse Models
por: Shin, Ha-Yeon, et al.
Publicado: (2022)

Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry
por: Kim, Bo Wook, et al.
Publicado: (2013)

Tetraspanin 1 promotes endometriosis leading to ovarian clear cell carcinoma
por: Shin, Ha‐Yeon, et al.
Publicado: (2021)

Mismatch Repair Protein Expression in Endometrial Cancer: Assessing Concordance and Unveiling Pitfalls in Two Different Immunohistochemistry Assays
por: Yoshida, Hiroshi, et al.
Publicado: (2023)

Makorin Ring Finger Protein 1 as Adjunctive Marker in Liquid-based Cervical Cytology
por: Lee, Maria, et al.
Publicado: (2016)

Comparison of the Mismatch Repair System between Primary and Metastatic Colorectal Cancers Using Immunohistochemistry
por: Jung, Jiyoon, et al.
Publicado: (2017)

DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells
por: Fukuhara, Shinichiro, et al.
Publicado: (2014)

Handcuffing intrinsically disordered regions in Mlh1–Pms1 disrupts mismatch repair
por: Furman, Christopher M, et al.
Publicado: (2021)

Accumulation of cytoplasmic Cdk1 is associated with cancer growth and survival rate in epithelial ovarian cancer
por: Yang, Wookyeom, et al.
Publicado: (2016)

TOM40 Inhibits Ovarian Cancer Cell Growth by Modulating Mitochondrial Function Including Intracellular ATP and ROS Levels
por: Yang, Wookyeom, et al.
Publicado: (2020)

Expression of the DNA mismatch repair proteins hMLH1 and hPMS2 in normal human tissues.
por: Fink, D., et al.
Publicado: (1997)

Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study
por: Goodfellow, Paul J., et al.
Publicado: (2015)

Mutations in the MutSα interaction interface of MLH1 can abolish DNA mismatch repair
por: Plotz, Guido, et al.
Publicado: (2006)

Functional implications of the p.Cys680Arg mutation in the MLH1 mismatch repair protein
por: Dominguez-Valentin, Mev, et al.
Publicado: (2014)

Mlh1 interacts with both Msh2 and Msh6 for recruitment during mismatch repair
por: DuPrie, Matthew L., et al.
Publicado: (2022)

p53 Immunohistochemistry and Mutation Types Mismatching in High-Grade Serous Ovarian Cancer
por: Park, Eunhyang, et al.
Publicado: (2022)

Promotores de participación /
por: García López, Alicia
Publicado: (1984)

Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review
por: Yokoyama, Takanori, et al.
Publicado: (2018)

The MLH1 polymorphism rs1800734 and risk of endometrial cancer with microsatellite instability
por: Russell, Holly, et al.
Publicado: (2020)

API5 induces cisplatin resistance through FGFR signaling in human cancer cells
por: Jang, Han Sol, et al.
Publicado: (2017)

Clinical significance of mismatch repair genes immunohistochemical expression of complex endometrial hyperplasia
por: Han, Su Jin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7f1n5ionplujet8fj0pah2ofn3